Literature DB >> 26795417

Do we screen very premature babies too early for retinopathy of prematurity?

G Kontos1, A Khan2, B W Fleck2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26795417      PMCID: PMC5108540          DOI: 10.1038/eye.2015.279

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Systemic effects of screening for retinopathy of prematurity.

Authors:  D E Laws; C Morton; M Weindling; D Clark
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

2.  UK retinopathy of prematurity guideline.

Authors:  A R Wilkinson; L Haines; K Head; A R Fielder
Journal:  Eye (Lond)       Date:  2008-10-03       Impact factor: 3.775

Review 3.  Screening examination of premature infants for retinopathy of prematurity.

Authors:  Walter M Fierson
Journal:  Pediatrics       Date:  2012-12-31       Impact factor: 7.124

4.  Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity.

Authors:  Ryan Rush; Sloan Rush; John Nicolau; Karen Chapman; Mubariz Naqvi
Journal:  Retina       Date:  2004-04       Impact factor: 4.256

5.  Severe visual impairment and blindness in children in the UK.

Authors:  Jugnoo S Rahi; Noriko Cable
Journal:  Lancet       Date:  2003-10-25       Impact factor: 79.321

  5 in total
  3 in total

1.  Effectiveness of the present ROP screening protocol.

Authors:  K Merchant; M Nassar; A Shafiq; D Cottrell
Journal:  Eye (Lond)       Date:  2016-07-29       Impact factor: 3.775

2.  Screening for retinopathy of prematurity can be started in postmenstrual week 31 in very premature babies!

Authors:  G Holmström; A Hellström; P Jakobsson; P Lundgren; K Tornqvist; A Wallin
Journal:  Eye (Lond)       Date:  2016-07-29       Impact factor: 3.775

3.  Retinal vascular development in an immature retina at 33-34 weeks postmenstrual age predicts retinopathy of prematurity.

Authors:  Ji Hye Jang; Yu Cheol Kim
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.